IN THE NEWS: Massive NIH-Industry Project Opens Portals to Target Validation
New Research from Michael Boehnke
Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.